Sponsor Dossier
Celltrion Healthcare
Sponsor Dossier for Celltrion Healthcare. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AVTOZMA
- Brand: EYDENZELT
- Brand: HERZUMA
- Brand: OMLYCLO
- Brand: OSENVELT
- Brand: REMSIMA
- Brand: STEQEYMA
- Brand: STOBOCLO
- Device (sponsor): Skin-cleaning wipe, sterile
- Device (sponsor): Antiseptic swab
About
Celltrion Healthcare is an Australian Private Company with ABN 66625407105, registered in NSW and currently active.
Portfolio
Celltrion Healthcare has 11 brands on the ARTG, of which 11 are indexable and 10 carry a Product Information document. 10 brands are PBS-listed, 8 have a PBAC outcome on record, and 10 have an AusPAR on record. Notable brands include AVTOZMA, EYDENZELT, HERZUMA, OMLYCLO, OSENVELT, REMSIMA, STEQEYMA, STOBOCLO, TRUXIMA, VEGZELMA, YUFLYMA.
Therapeutic focus
— Immunology: 6 brands — Oncology: 3 brands — Ophthalmology: 1 brand — Musculoskeletal: 1 brand
PBS footprint
10 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-07-01, across 8 brands with a PBAC outcome on record. The latest AusPAR is 2025-12-16, across 10 brands with an AusPAR on record.